Navigation Links
Bristol-Myers Squibb, New Jersey Children's Hospital Launch Center for Immune System Disorders & Infectious Diseases Including HIV/AIDS
Date:11/30/2007

NEW BRUNSWICK, N.J., Nov. 30 /PRNewswire-FirstCall/ -- Underscoring its worldwide commitment to children with HIV/AIDS, Bristol-Myers Squibb Company (NYSE: BMY) today joined Robert Wood Johnson University Hospital in opening a new clinical center at The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital. The new center is dedicated to research and treatment of children's immune system disorders and infectious diseases.

The Bristol-Myers Squibb Pediatric Infectious Disease and Immunology Center is one of three new clinical centers at the children's hospital made possible by a $5 million gift from the Bristol-Myers Squibb Foundation.

"At Bristol-Myers Squibb, we believe that together we can prevail over serious illness," said Jill DeSimone, senior vice president of the company's U.S. Virology division. "We are committed as a company in the battle against HIV/AIDS here in our community and throughout the world, and we stand united with others who are working to improve the lives of children and all people afflicted with this debilitating disease."

The new infectious disease and immunology center is the latest example of the company's support for the New Brunswick children's hospital, built in part with a philanthropic gift from Bristol-Myers Squibb Foundation. The center will not only treat pediatric HIV, it will also focus on emerging resistant infections, including those caused by community-acquired methicillin resistant Staphylococcus aureus (MRSA).

This past spring, The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital opened a pediatric rheumatology center dedicated to the research and treatment of rheumatic diseases such a
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. MedImmunes Motavizumab Reduced RSV Hospitalizations by 83 Percent Among High-Risk Native American, Full-Term Infants in Placebo-Controlled Phase 3 study
2. Gilbert Hospital Continues Cutting Edge Treatments
3. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
4. New Data Show Doripenem as Effective as Commonly Used Therapies in Treating Hospital-Acquired Pneumonias
5. AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study
6. INVEGA(TM) Significantly Reduced Symptoms of Schizophrenia Compared to SEROQUEL(R) in Acutely Ill, Hospitalized Patients
7. Cardinal Health Releases New Tool to Combat MRSA Infections in Hospitals
8. Hospital to Hold MRSA Briefing for Media and Community Leaders
9. Arizona Heart Hospital Reaches Settlement Regarding Clinical Research Matter
10. Providence Hospital Study Finds Communication System Leads to Faster Heart Attack Treatment
11. Allegheny General Hospital Performs First Liver Transplant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... 5, 2015 /CNW Telbec/ - Ergoresearch Ltd ... and known under the « Équilibre, orthèses ... the transaction previously announced on April 23, 2015 regarding ...  shares of Orthoconcept (2008) inc.   The ... shares (TSXV: ERG) to the vending shareholder, namely 9211-5096 ...
(Date:5/5/2015)... Valley Medical Center, named a Top 100 Hospitals® in the ... to deploy the wireless Leaf Patient Monitoring System in its ... labor and risk of caesarian births. Studies show ... is reduced in mothers who are upright and mobile during ... epidurals and tend to lie in their labor room beds. ...
(Date:5/5/2015)... , May 5, 2015  IQPC,s 19 th ... announce the chairman of the Summit Mr. Phani Bidarahalli ... will be joined by the expert speaker faculty including senior ... May 11 – 12, at The Hotel Kabuki in ... is available for download on the event website, which can ...
Breaking Medicine Technology:Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 2Ergoresearch announces closing of the acquisition of 49% of the shares of Orthoconcept (2008) inc. 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 2Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 3Desert Valley Medical Center First to Use Leaf Patient-Wearable Technology to Help Reduce C-Sections, Speed Labor 4Phani Bidarahalli from Wipro to chair the upcoming 19th Software Design for Medical Devices Summit in San Francisco 2
... 17, 2011 Inovio Pharmaceuticals, Inc. (NYSE Amex: ... Animal Health, Inc., a developer of DNA-based vaccines and ... T cell responses from VAH-5000D, its DNA vaccine encoding ... with cancer. This preclinical data was presented by Dr. ...
... Terumo Cardiovascular Systems (Terumo CVS) announced today that ... a Class I action the company,s recent voluntary recall ... instances of adhesive build-up and/or skiving of plastic (plastic ... defect was discovered during in-house inspection after Terumo CVS ...
Cached Medicine Technology:VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 2VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 3VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 4FDA Classifies Recent Terumo CVS Recall of Coronary Ostia Cannulae as Class I Action 2
(Date:5/5/2015)... DC (PRWEB) May 05, 2015 ... Optimity) will present at the 24th ... at 1:15 p.m. MT in Scottsdale, AZ. WEDI, ... nation’s leading nonprofit authority on the use of ... exchange. Donald Graf, National Director of Telemedicine for ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 From ... the established leader in enabling enterprise collaboration ... to help customers speed up and simplify the ... technologies, AvePoint Solutions for Office 365 ... faster while ensuring sustainable user adoption and effectively ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
(Date:5/5/2015)... " QuickPick Travel ” was featured on ... a look small, medium, and large businesses making an impact ... a business expert, conducted the business review and shared with ... to three weeks of vacation for free. , Vacations are ... explore the world. And when people are preparing for vacations, ...
(Date:5/5/2015)... 2015 Information Innovators Inc. ... the federal government, today announced its acquisition of ... provides solutions exclusively to federal government customers through ... cyber security, health services, and program management support. ... credentials as a Third Party Assessment Organization (3PAO) ...
Breaking Medicine News(10 mins):Health News:Optimity Advisors’ Hiliary Critchley, Telemedicine Expert, to Speak at WEDI Conference May 20th in Scottsdale, AZ 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 2Health News:AvePoint Unveils New Solutions for Microsoft Office 365 & Azure at Microsoft Ignite 2015 3Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3Health News:A Platform to Plan the Perfect Vacation was Featured on NewsWatch Television 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 2Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 3Health News:Information Innovators Inc. (Triple-i) Acquires Leading Cyber Security and Health-Focused Solutions Company, Creative Computing Solutions, Inc. 4
... REVENUES UP 35% VERSUS FULL YEAR 2006, BRANCHBURG, ... today reported financial results for the fourth,quarter and full ... Executive Officer, will host a conference call today at ... year financial results., Fourth Quarter 2007 Results, ...
... Physicians Report Satisfaction with GlaxoSmithKline,s Advair and,Boehringer ... Novel, Anti-Inflammatory Drug, According to a New ... Feb. 27 Decision Resources, one of ... on pharmaceutical and,healthcare issues, finds that surveyed ...
... EXTON, Pa., Feb. 27 ViroPharma Incorporated,(Nasdaq: VPHM ) ... months ended December 31, 2007., Key events since ... Drug Designation received for Camvia(TM) (maribavir); -- Patient enrollment ... cell and solid organ transplant patients; ...
... Body, Mind & Spirit, VAIL, Colo., Feb. ... healthcare, Next Step(R) Institute of Integrative,Medicine, Inc., headquartered ... recently announced its 2008 series of life-changing,Wellness Weeks ... Institute Wellness Weeks are six-night, five-day programs,that promote ...
... Overweight Hispanic children with normal blood glucose (sugar) levels showed ... to developing both type 2 diabetes and cardiovascular disease, says ... Center. , The study, published in the March issue of ... already known to be at high risk for developing type ...
... new article suggests that the United States government ... Cuba into a biomedical research institute dedicated to ... the open-access journal PLoS Neglected Tropical Diseases, Editor-in-Chief ... be in an optimal position to directly address ...
Cached Medicine News:Health News:LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results 2Health News:LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results 3Health News:LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results 4Health News:LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results 5Health News:LifeCell Reports Fourth Quarter and Full Year 2007 Financial Results 6Health News:A Once-Daily Oral Drug for Chronic Obstructive Pulmonary Disease That Treats COPD-Related Inflammation Could Achieve Blockbuster Status 2Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 2Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 3Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 4Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 5Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 6Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 7Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 8Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 9Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 10Health News:ViroPharma Incorporated Reports Fourth Quarter and Full Year 2007 Financial Results 11Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 2Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 3Health News:Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks 4Health News:Overweight Hispanic children shown to have vascular inflammation 2Health News:From detainee facility to health advocacy center: A new role for Guantanamo? 2
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Amylase (EPS-G7, kinetics), Wavelength: 405 nm. Linear range; 5-1500 IU/L....
Intended for the quantitative determination of alphaamylase activity in serum. Single vial, dry powder reagent. Reaction: Kinetic. Wavelength: 405 nm. Linearity: 2000 U/L at 37C....
For the direct, colorimetric determination of calcium in human serum or urine. Linearity: 20 mg/dl....
Medicine Products: